- Home
- HERZ vs MODD Comparison
HERZ vs MODD Comparison
Compare HERZ & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$4.46
Company Overview
Basic Information| Metric | HERZ | MODD |
|---|---|---|
| Founded | N/A | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.3M | 28.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HERZ | MODD |
|---|---|---|
| Price | $17.10 | $4.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.1K | ★ 121.5K |
| Earning Date | N/A | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $0.12 |
| 52 Week High | $19.30 | $6.16 |
Technical Indicators
Market Signals| Indicator | HERZ | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 50.55 |
| Support Level | $15.61 | $4.19 |
| Resistance Level | $17.59 | $5.84 |
| Average True Range (ATR) | 0.79 | 0.64 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 57.22 | 25.84 |
Price Performance
Historical Comparison HERZ
MODD
About HERZ Herzfeld Credit Income Fund Inc.
Herzfeld Credit Income Fund Inc is a non-diversified, closed-end management investment company. Its primary investment objective is to maximize risk-adjusted total returns, and its secondary investment objective is to generate high current income.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.